• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过生物信息学分析鉴定在肾透明细胞癌中具有预后影响的显著基因。

Identification of significant genes with prognostic influence in clear cell renal cell carcinoma via bioinformatics analysis.

作者信息

Zhang Fangyuan, Wu Pengjie, Wang Yalong, Zhang Mengxian, Wang Xiaodan, Wang Ting, Li Shengwen, Wei Dong

机构信息

School of Clinical Medicine, Tsinghua University, Beijing 100084, China.

Department of Urology, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.

出版信息

Transl Androl Urol. 2020 Apr;9(2):452-461. doi: 10.21037/tau.2020.02.11.

DOI:10.21037/tau.2020.02.11
PMID:32420151
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7215011/
Abstract

BACKGROUND

Clear cell renal cell carcinoma (ccRCC) is the most common malignant tumor of kidney with high mortality. The pathogenesis of ccRCC is complicated and effective prognostic predictors for clinical practice are still limited. This study aimed to identify significant genes with prognostic influence in ccRCC via bioinformatics analysis.

METHODS

Four gene expression profiles were acquired from the Gene Expression Omnibus (GEO) database, including 168 ccRCC tissues and 143 normal tissues. Common differentially expressed genes (DEGs) between ccRCC tissues and normal kidney tissues were screened out. Then gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were investigated. Protein-protein interaction (PPI) network of the common DEGs was diagrammed and analyzed. Kaplan-Meier analysis was conducted to identify genes with prognostic influence in ccRCC. Gene Expression Profiling Interactive Analysis (GEPIA) was finally applied to validating differential expression of genes.

RESULTS

Ninety-nine common DEGs between ccRCC tissues and normal kidney tissues were eventually screened out (P<0.05, |log FC| >2). GO functional analysis showed that the down-regulated genes were enriched in excretion, negative regulation of cell proliferation, heparin binding and cellular response to BMP stimulus, etc. KEGG pathway analysis indicated that the common DEGs were particularly enriched in HIF-1 signaling pathway and aldosterone-regulated sodium reabsorption. Seven core DEGs were distinguished through PPI network analysis, of which 6 core genes , , , , and showed significantly prognostic difference in patients with ccRCC by Kaplan-Meier analysis (P<0.05). And GEPIA confirmed these genes were expressed differentially between tumor and normal tissues (P<0.05). High expression of was correlated with good OS in ccRCC patients. Specifically, was commonly down-regulated in ccRCC tissues compared with normal tissues according to GEPIA.

CONCLUSIONS

Our study shows that high expression of denotes a better prognosis in ccRCC patients. is down-regulated in ccRCC tissues compared with normal kidney tissues. The selective expression pattern suggests that could be a novel prognostic predictor and potential therapeutic target for ccRCC patients.

摘要

背景

透明细胞肾细胞癌(ccRCC)是最常见的肾脏恶性肿瘤,死亡率高。ccRCC的发病机制复杂,临床实践中有效的预后预测指标仍然有限。本研究旨在通过生物信息学分析确定在ccRCC中具有预后影响的重要基因。

方法

从基因表达综合数据库(GEO)中获取四个基因表达谱,包括168例ccRCC组织和143例正常组织。筛选出ccRCC组织与正常肾组织之间的常见差异表达基因(DEGs)。然后进行基因本体(GO)富集分析和京都基因与基因组百科全书(KEGG)通路分析。绘制并分析常见DEGs的蛋白质-蛋白质相互作用(PPI)网络。进行Kaplan-Meier分析以确定在ccRCC中具有预后影响的基因。最后应用基因表达谱交互式分析(GEPIA)验证基因的差异表达。

结果

最终筛选出ccRCC组织与正常肾组织之间的99个常见DEGs(P<0.05,|log FC|>2)。GO功能分析表明,下调基因富集于排泄、细胞增殖的负调控、肝素结合和细胞对BMP刺激的反应等。KEGG通路分析表明,常见DEGs特别富集于HIF-1信号通路和醛固酮调节的钠重吸收。通过PPI网络分析鉴别出7个核心DEGs,其中6个核心基因,,,,和通过Kaplan-Meier分析显示在ccRCC患者中具有显著的预后差异(P<0.05)。并且GEPIA证实这些基因在肿瘤组织和正常组织之间表达存在差异(P<0.05)。在ccRCC患者中,的高表达与良好的总生存期相关。具体而言,根据GEPIA,与正常组织相比,在ccRCC组织中通常下调。

结论

我们的研究表明,在ccRCC患者中高表达表示预后较好。与正常肾组织相比,在ccRCC组织中下调。这种选择性表达模式表明,可能是ccRCC患者一种新 的预后预测指标和潜在的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c5/7215011/f576c51b98e6/tau-09-02-452-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c5/7215011/546a18878753/tau-09-02-452-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c5/7215011/cc508e30f537/tau-09-02-452-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c5/7215011/b83055cb5c5a/tau-09-02-452-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c5/7215011/f576c51b98e6/tau-09-02-452-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c5/7215011/546a18878753/tau-09-02-452-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c5/7215011/cc508e30f537/tau-09-02-452-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c5/7215011/b83055cb5c5a/tau-09-02-452-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29c5/7215011/f576c51b98e6/tau-09-02-452-f4.jpg

相似文献

1
Identification of significant genes with prognostic influence in clear cell renal cell carcinoma via bioinformatics analysis.通过生物信息学分析鉴定在肾透明细胞癌中具有预后影响的显著基因。
Transl Androl Urol. 2020 Apr;9(2):452-461. doi: 10.21037/tau.2020.02.11.
2
Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis.通过生物信息学分析对透明细胞肾细胞癌中新型关键基因ITGAX、LAPTM5、SERPINE1进行预测与分析
PeerJ. 2021 Apr 20;9:e11272. doi: 10.7717/peerj.11272. eCollection 2021.
3
Bioinformatics analysis of C3 and CXCR4 demonstrates their potential as prognostic biomarkers in clear cell renal cell carcinoma (ccRCC).C3 和 CXCR4 的生物信息学分析表明它们可能成为透明细胞肾细胞癌 (ccRCC) 的预后生物标志物。
BMC Cancer. 2021 Jul 15;21(1):814. doi: 10.1186/s12885-021-08525-w.
4
Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.通过综合生物信息学分析鉴定 CXCL13 作为透明细胞肾细胞癌的潜在生物标志物。
Biomed Pharmacother. 2019 Oct;118:109264. doi: 10.1016/j.biopha.2019.109264. Epub 2019 Aug 4.
5
Identification of Prognostic Related Hub Genes in Clear-Cell Renal Cell Carcinoma Bioinformatical Analysis.透明细胞肾细胞癌预后相关枢纽基因的鉴定 生物信息学分析。
Chin Med Sci J. 2021 Jun 30;36(2):127-134. doi: 10.24920/003651.
6
Identification of TYROBP and FCER1G as Key Genes with Prognostic Value in Clear Cell Renal Cell Carcinoma by Bioinformatics Analysis.生物信息学分析鉴定透明细胞肾细胞癌中具有预后价值的关键基因 TYROBP 和 FCER1G。
Biochem Genet. 2021 Oct;59(5):1278-1294. doi: 10.1007/s10528-021-10061-y. Epub 2021 Mar 30.
7
Identification of CXCL10 as a Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.鉴定CXCL10作为透明细胞肾细胞癌的预后生物标志物
Front Oncol. 2022 Feb 28;12:857619. doi: 10.3389/fonc.2022.857619. eCollection 2022.
8
Integrated bioinformatics analysis to identify the key gene associated with metastatic clear cell renal cell carcinoma.综合生物信息学分析鉴定与转移性透明细胞肾细胞癌相关的关键基因。
Med Oncol. 2022 Jun 18;39(9):128. doi: 10.1007/s12032-022-01706-y.
9
Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.通过生物信息学分析鉴定肺腺癌中具有预后价值的关键基因和潜在的肿瘤抑制因子。
BMC Cancer. 2021 May 26;21(1):616. doi: 10.1186/s12885-021-08308-3.
10
Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.鉴定透明细胞肾细胞癌的生物标志物和潜在的分子机制。
Neoplasma. 2018;65(2):242-252. doi: 10.4149/neo_2018_170511N342.

引用本文的文献

1
Diagnostic and prognostic relevance of gene in acute myeloid leukemia.基因在急性髓系白血病中的诊断和预后相关性
Leuk Res Rep. 2025 Jul 10;24:100528. doi: 10.1016/j.lrr.2025.100528. eCollection 2025.
2
Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target.血管生成素样蛋白4在肾脏疾病中的失调:一种有前景的生物标志物和治疗靶点。
Front Pharmacol. 2025 Jan 7;15:1475198. doi: 10.3389/fphar.2024.1475198. eCollection 2024.
3
Identification and Validation of Cytotoxicity-Related Features to Predict Prognostic and Immunotherapy Response in Patients with Clear Cell Renal Cell Carcinoma.

本文引用的文献

1
Three novel hub genes and their clinical significance in clear cell renal cell carcinoma.三种新型枢纽基因及其在肾透明细胞癌中的临床意义
J Cancer. 2019 Nov 1;10(27):6779-6791. doi: 10.7150/jca.35223. eCollection 2019.
2
Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.通过综合生物信息学分析鉴定 CXCL13 作为透明细胞肾细胞癌的潜在生物标志物。
Biomed Pharmacother. 2019 Oct;118:109264. doi: 10.1016/j.biopha.2019.109264. Epub 2019 Aug 4.
3
Asynchronous abdominal wall and sigmoid metastases in clear cell renal cell carcinoma: A case report and literature review.
鉴定和验证与细胞毒性相关的特征,以预测透明细胞肾细胞癌患者的预后和免疫治疗反应。
Genet Res (Camb). 2024 Aug 30;2024:3468209. doi: 10.1155/2024/3468209. eCollection 2024.
4
Identification of key genes and signalling pathways in clear cell renal cell carcinoma: An integrated bioinformatics approach.透明细胞肾细胞癌关键基因和信号通路的鉴定:一种综合的生物信息学方法。
Cancer Biomark. 2024;40(1):111-123. doi: 10.3233/CBM-230271.
5
An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many Cancers.一种基于 CD10 细胞的分子特征和相关干性生物标志物的早期肿瘤指数(ENI10),是许多癌症患者预后的预测因子。
Cancer Res Commun. 2023 Sep 29;3(9):1966-1980. doi: 10.1158/2767-9764.CRC-23-0196.
6
Expression of Predicts Prognosis of Clear Cell Renal Cell Carcinoma.[具体指标]的表达预测透明细胞肾细胞癌的预后。 (原文中“Expression of ”后面缺少具体内容)
Front Genet. 2021 Jul 5;12:683173. doi: 10.3389/fgene.2021.683173. eCollection 2021.
7
The Choice of Candidates in Survival Markers Based on Coordinated Gene Expression in Renal Cancer.基于肾癌中协调基因表达的生存标志物候选物的选择
Front Oncol. 2021 May 11;11:615787. doi: 10.3389/fonc.2021.615787. eCollection 2021.
透明细胞肾细胞癌的异步性腹壁和乙状结肠转移:一例报告及文献综述
Asian J Urol. 2019 Apr;6(2):210-214. doi: 10.1016/j.ajur.2018.01.001. Epub 2018 Jan 6.
4
Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.通过生物信息学分析和荟萃分析鉴定 EGFR 为透明细胞肾细胞癌(ccRCC)中的一个新的关键基因。
Biomed Res Int. 2019 Feb 13;2019:6480865. doi: 10.1155/2019/6480865. eCollection 2019.
5
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.欧洲泌尿外科学会肾癌指南:2019 年更新版。
Eur Urol. 2019 May;75(5):799-810. doi: 10.1016/j.eururo.2019.02.011. Epub 2019 Feb 23.
6
Identifying a Novel Biomarker of Clear Cell Renal Cell Carcinoma (ccRCC) Associated with Smoking by Co-Expression Network Analysis.通过共表达网络分析鉴定与吸烟相关的透明细胞肾细胞癌(ccRCC)的新型生物标志物
J Cancer. 2018 Oct 10;9(21):3912-3922. doi: 10.7150/jca.25900. eCollection 2018.
7
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
8
Prognostic factors and prognostic models for renal cell carcinoma: a literature review.肾细胞癌的预后因素和预后模型:文献综述。
World J Urol. 2018 Dec;36(12):1943-1952. doi: 10.1007/s00345-018-2309-4. Epub 2018 Apr 30.
9
Identification of key genes and pathways in human clear cell renal cell carcinoma (ccRCC) by co-expression analysis.通过共表达分析鉴定人透明细胞肾细胞癌(ccRCC)中的关键基因和通路。
Int J Biol Sci. 2018 Feb 12;14(3):266-279. doi: 10.7150/ijbs.23574. eCollection 2018.
10
Identification of biomarkers and potential molecular mechanisms of clear cell renal cell carcinoma.鉴定透明细胞肾细胞癌的生物标志物和潜在的分子机制。
Neoplasma. 2018;65(2):242-252. doi: 10.4149/neo_2018_170511N342.